Watch Live

Tweet TWEET

WuXi PharmaTech Schedules Second-Quarter 2013 Earnings Release

        WuXi PharmaTech Schedules Second-Quarter 2013 Earnings Release

PR Newswire

SHANGHAI, July 15, 2013

SHANGHAI, July 15, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:
WX), a leading pharmaceutical, biotechnology and medical device R&D
outsourcing company with operations in China and the United States, today
announced that it will release financial results for the second quarter of
2013 after the New York Stock Exchange closes on Monday, August 12, 2013
(which will be Tuesday morning, August 13, 2013 Shanghai time). The earnings
release will be available on the investor relations section of the Company's
website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will
host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) /
8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, August 13, 2013, to discuss
the second-quarter 2013 financial results and recent business activities. The
conference call may be accessed by calling:

Australia                       1800 801 825
Belgium              0800 784 01
Canada              1855 842 3490
China            4001 200 539
France             0800 916 599
Germany                0800 1899 399
Hong Kong                 800 905 927
Hong Kong (toll)        +852 5808 3202
India          000 800 100 8255
Indonesia               00180 301 91840
Ireland            1800 720 105
Italy                   800 875 577
Japan            0120 271 900
Malaysia                        1800 816 107
Netherlands                  0800 0234 240
New Zealand                    0800 452 905
Singapore                800 616 3222
South Korea                  00798 6136 1434
Sweden               0207 968 70
Switzerland                 0800 837 001
Taiwan             0080 161 5189
United Kingdom             0800 015 9725
United Kingdom—London (toll) 44 (0) 20 3078 7622
United States                   1855 298 3404
United States—New York (toll)    +1 631 5142 526
Other countries (toll)  +65 6823 2299
Conference ID:           1007691

A telephone replay will be available two hours after the call's completion at:

Australia             1800 008 585
Belgium              0800 11 797
Canada              1866 4783 460
China           4001 842 240
France            0800 904 160
Germany                0800 181 3763
Hong Kong       800 966 697
India          000 800 100 6647
Indonesia     0018 0306 12086
Ireland            1800 511 665
Italy                  800 784 706
Japan           0066 3386 1031
Malaysia              1800 181 061
Netherlands        08000 232 153
New Zealand          0800 444 310
Singapore      800 616 2127
South Korea        00798 612 1058
Sweden              020 792 274
Switzerland       0800 564 016
Taiwan             00801 232 352
United Kingdom   0800 169 7301
United States         1866 846 0868
Conference ID: 1007691

A live webcast of the conference call and replay will be available in the
investor relations section of WuXi PharmaTech's website at
http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device
R&D outsourcing company, with operations in China and the United States. As a
research-driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical, biotechnology and medical device companies with a broad and
integrated portfolio of laboratory and manufacturing services throughout the
drug and medical device R&D process. WuXi PharmaTech's services are designed
to help its global partners in shortening the cycle and lowering the cost of
drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com



SOURCE WuXi PharmaTech (Cayman) Inc.

Website: http://www.wuxiapptec.com